134 related articles for article (PubMed ID: 34265468)
1. IgM single antigen bead HLA-assay is affected by imlifidase through the cleavage of IgG but not IgM.
Runström A; Sjöholm K; Roupé KM; Lorant T; Kjellman C; Bockermann R
Transpl Immunol; 2021 Oct; 68():101436. PubMed ID: 34265468
[TBL] [Abstract][Full Text] [Related]
2. Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.
Moreno Gonzales MA; Mitema DG; Smith BH; Schinstock CA; Stegall MD; Wakefield LL; Henderson NA; DeGoey SR; Kreuter JD; Gandhi MJ
Transplant Proc; 2017 Nov; 49(9):2031-2035. PubMed ID: 29149956
[TBL] [Abstract][Full Text] [Related]
3. The ABCs (DRDQDPs) of the prozone effect in single antigen bead HLA antibody testing: Lessons from our highly sensitized patients.
Greenshields AL; Liwski RS
Hum Immunol; 2019 Jul; 80(7):478-486. PubMed ID: 31080010
[TBL] [Abstract][Full Text] [Related]
4. Getting on target: Development of the novel, prozone-resistant, dual antibody rapid test (DART) for the LABScreen single antigen bead (SAB) assay.
Greenshields A; Bray RA; Gebel HM; Liwski RS
Hum Immunol; 2019 Jul; 80(7):468-477. PubMed ID: 31040048
[TBL] [Abstract][Full Text] [Related]
5. IgM marks persistent IgG anti-human leukocyte antigen antibodies in highly sensitized heart transplant patients.
Li F; Gragert L; Giovanni Biagini D; Patel JK; Kobashigawa JA; Trück J; Rodriguez O; Watson CT; Gibb DR; Zhang X; Kransdorf EP
J Heart Lung Transplant; 2024 Feb; 43(2):314-323. PubMed ID: 37793509
[TBL] [Abstract][Full Text] [Related]
6. Imlifidase-generated Single-cleaved IgG: Implications for Transplantation.
Bockermann R; Järnum S; Runström A; Lorant T; Winstedt L; Palmqvist N; Kjellman C
Transplantation; 2022 Jul; 106(7):1485-1496. PubMed ID: 34966107
[TBL] [Abstract][Full Text] [Related]
7. Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.
Taylor CJ; Kosmoliaptsis V; Martin J; Knighton G; Mallon D; Bradley JA; Peacock S
Transplantation; 2017 Jun; 101(6):1206-1214. PubMed ID: 27306532
[TBL] [Abstract][Full Text] [Related]
8. Impact of imlifidase treatment on immunoglobulins in an HLA-hypersensitized lupus nephritis patient with anti-SSA/SSB antibodies after kidney transplantation: A case report.
Milhès J; Marion O; Puissant B; Carlé C; Bouthemy C; Del Bello A; Kamar N; Renaudineau Y; Congy-Jolivet N
J Transl Autoimmun; 2023 Dec; 7():100223. PubMed ID: 38162455
[TBL] [Abstract][Full Text] [Related]
9. The impact of IdeS (imlifidase) on allo-specific, xeno-reactive, and protective antibodies in a sensitized rhesus macaque model.
DeLaura I; Zikos J; Anwar IJ; Yoon J; Ladowski J; Jackson A; Van Rompay K; Magnani D; Knechtle SJ; Kwun J
Xenotransplantation; 2024; 31(1):e12833. PubMed ID: 37864433
[TBL] [Abstract][Full Text] [Related]
10. Determinants of C1q binding in the single antigen bead assay.
Schaub S; Hönger G; Koller MT; Liwski R; Amico P
Transplantation; 2014 Aug; 98(4):387-93. PubMed ID: 24918611
[TBL] [Abstract][Full Text] [Related]
11. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
Llorente S; Boix F; Eguia J; López M; Bosch A; Martinez H; Gonzalez MJ; López-Hernández R; Salgado G; Moya-Quiles MR; Campillo JA; García-Alonso AM; Minguela A; Jimeno L; Alvarez-López MR; Muro M
Transplant Proc; 2012 Nov; 44(9):2535-7. PubMed ID: 23146446
[TBL] [Abstract][Full Text] [Related]
12. Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies.
Kosmoliaptsis V; Bradley JA; Peacock S; Chaudhry AN; Taylor CJ
Transplantation; 2009 Mar; 87(6):813-20. PubMed ID: 19300182
[TBL] [Abstract][Full Text] [Related]
13. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.
Zeevi A; Lunz J; Feingold B; Shullo M; Bermudez C; Teuteberg J; Webber S
J Heart Lung Transplant; 2013 Jan; 32(1):98-105. PubMed ID: 23142561
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays.
Navas A; Molina J; Agüera ML; Guler I; Jurado A; Rodríguez-Benot A; Alonso C; Solana R
Front Immunol; 2019; 10():1712. PubMed ID: 31428086
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Anti-HLA Antibodies of Highly Sensitized Patients by Single Antigen Bead and C1q Tests.
Ayna TK; Koçyİğİt AÖ; Soypaçaci Z; Tuğmen C; Pirim I
Transplant Proc; 2019 May; 51(4):1024-1026. PubMed ID: 31101164
[TBL] [Abstract][Full Text] [Related]
16. From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.
Claisse G; Mariat C; Maillard N
Clin Transpl; 2016; 32():153-160. PubMed ID: 28564533
[TBL] [Abstract][Full Text] [Related]
17. In-Depth Analysis of Anti-HLA Antibodies Using C1q Assay.
Zielińska H; Zieliński M; Dębska-Zielkowska J; Dukat-Mazurek A; Moszkowska G; Lewandowska D; Dębska-Ślizień A; Trzonkowski P
Transplant Proc; 2022 May; 54(4):934-939. PubMed ID: 35534279
[TBL] [Abstract][Full Text] [Related]
18. The correlation of results of panel reactive antibody, identification, and single antigen beads in detection of anti-HLA antibodies: Istanbul Faculty of Medicine, tissue typing laboratory experience.
Ciftci HS; Oguz FS; Cinar CK; Izgi DK
Transpl Immunol; 2023 Oct; 80():101891. PubMed ID: 37433395
[TBL] [Abstract][Full Text] [Related]
19. Determination of unacceptable antigens by summation of anti-HLA eplet antibody strength (MFI) based on single antigen bead assays: Excellent correlation with negative cell based cross matches.
Norin AJ; Das B; Mondragon-Escorpizo MO; Bajaj H; Sumrani N; John D; Salifu MO
Hum Immunol; 2022 Jun; 83(6):482-493. PubMed ID: 35469692
[TBL] [Abstract][Full Text] [Related]
20. Imlifidase therapy: exploring its clinical uses.
Rostaing L; Noble J; Malvezzi P; Jouve T
Expert Opin Pharmacother; 2023 Feb; 24(2):259-265. PubMed ID: 36404277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
